Breaking News Instant updates and real-time market news.

ACRX

AcelRx

$4.10

-0.05 (-1.20%)

11:10
10/19/18
10/19
11:10
10/19/18
11:10

AcelRx attracts downside put buying

AcelRx attracts downside put buying. The stock off 6c to $4.09 and 6K Nov 2.5 puts trade for 30c when bid-ask was 20 to 30c. 6.5K trade total after recent volatility in shares - the stock sank to a low of $2.43 on 10/10 after the release of FDA briefing docs related to efficacy of DSUVIA, but has since rallied 68% and notched 52-week highs of $5.03 earlier this week. Nov 2.5 puts likely replace the expiring Oct 2.5 puts (open interest is 6K) to hedge stock ahead of a company presentation at a Credit Suisse conference on 11/13. 30-day implied volatility down 7% Friday, but remains elevated at 182.

  • 03

    Nov

ACRX AcelRx
$4.10

-0.05 (-1.20%)

10/10/18
HCWC
10/10/18
NO CHANGE
Target $7
HCWC
Buy
AcelRx briefing docs bode well for positive panel, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce believes the briefing document released this morning for the October 12 FDA meeting to review the resubmitted new drug application of Dsuvia bode well for a positive panel vote. The statements and tone of the FDA reviewers are broadly supportive of approval, Arce tells investors in a research note. The analyst affirms a Buy rating on AcelRx Pharmaceuticals with a $7 price target.
10/15/18
JEFF
10/15/18
UPGRADE
Target $8
JEFF
Buy
AcelRx upgraded to Buy from Hold at Jefferies
Jefferies analyst Roger Song upgraded AcelRx upgraded AcelRx Pharmaceuticals to Buy and raised his price target for the shares to $8 from $3. The analyst sees a high chance of approval for Dsuvia following Friday's positive FDA panel vote.
10/15/18
CANT
10/15/18
NO CHANGE
Target $8
CANT
Overweight
AcelRx price target raised to $8 from $6 at Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes raised his price target for AcelRx to $8 citing increased conviction that Dsuvia will be approved by the FDA on its November 3 action date following Friday's positive panel vote. AcelRx could have two product approvals within the next 12 months, along with the potential to launch or partner Dsuvia in Europe after approval earlier this year, Folkes tells investors in a research note. He believes upward earnings revisions will drive upside momentum in the stock and reiterates an Overweight rating on the name.
10/15/18
HCWC
10/15/18
NO CHANGE
Target $8
HCWC
Buy
H.C. Wainwright sees Dsuvia approval coming, raises AcelRx price target to $8
After AcelRx presented data from an enhanced application to an FDA expert panel one year after announcing a CRL on the original application for Dsuvia, H.C. Wainwright analyst Ed Arce now sees the drug being poised for approval following the panel's positive 10-3 vote. Ahead of what he sees as a Dsuvia launch in the first quarter of 2019, Arce raised his price target on AcelRx shares to $8 from $7 and keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

BBY

Best Buy

$69.85

0.11 (0.16%)

07:55
03/20/19
03/20
07:55
03/20/19
07:55
Initiation
Best Buy initiated  »

Best Buy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENV

Envestnet

$66.69

0.29 (0.44%)

07:54
03/20/19
03/20
07:54
03/20/19
07:54
Downgrade
Envestnet rating change  »

Envestnet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$181.50

-0.92 (-0.50%)

07:54
03/20/19
03/20
07:54
03/20/19
07:54
Recommendations
FedEx analyst commentary  »

FedEx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 02

    Apr

  • 25

    Jun

TSCO

Tractor Supply

$91.14

1.34 (1.49%)

07:53
03/20/19
03/20
07:53
03/20/19
07:53
Initiation
Tractor Supply initiated  »

Tractor Supply initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIK

Michaels

$12.78

0.99 (8.40%)

07:52
03/20/19
03/20
07:52
03/20/19
07:52
Downgrade
Michaels rating change  »

Michaels downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXG

Bluegreen Vacations

$16.10

0.06 (0.37%)

07:51
03/20/19
03/20
07:51
03/20/19
07:51
Initiation
Bluegreen Vacations initiated  »

Bluegreen Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHW

Sherwin-Williams

$430.33

-1.145 (-0.27%)

07:51
03/20/19
03/20
07:51
03/20/19
07:51
Initiation
Sherwin-Williams initiated  »

Sherwin-Williams…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

WYNN

Wynn Resorts

$117.80

1.67 (1.44%)

07:50
03/20/19
03/20
07:50
03/20/19
07:50
Initiation
Wynn Resorts initiated  »

Wynn Resorts assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LL

Lumber Liquidators

$9.69

-0.12 (-1.22%)

07:50
03/20/19
03/20
07:50
03/20/19
07:50
Initiation
Lumber Liquidators initiated  »

Lumber Liquidators…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVY

Avery Dennison

$112.26

0.615 (0.55%)

07:50
03/20/19
03/20
07:50
03/20/19
07:50
Downgrade
Avery Dennison rating change  »

Avery Dennison downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WYND

Wyndham Destinations

$41.29

-0.855 (-2.03%)

07:49
03/20/19
03/20
07:49
03/20/19
07:49
Initiation
Wyndham Destinations initiated  »

Wyndham Destinations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

07:48
03/20/19
03/20
07:48
03/20/19
07:48
Initiation
Scientific Games initiated  »

Scientific Games assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$19.24

-0.04 (-0.21%)

07:48
03/20/19
03/20
07:48
03/20/19
07:48
Recommendations
Overstock.com analyst commentary at DA Davidson »

Overstock.com 10K filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$103.48

1.6 (1.57%)

07:48
03/20/19
03/20
07:48
03/20/19
07:48
Initiation
Lowe's initiated  »

Lowe's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

MGP

MGM Growth

$30.69

0.15 (0.49%)

07:47
03/20/19
03/20
07:47
03/20/19
07:47
Initiation
MGM Growth initiated  »

MGM Growth assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$73.75

-0.54 (-0.73%)

07:47
03/20/19
03/20
07:47
03/20/19
07:47
Hot Stocks
Jacobs Engineering awarded U.S. Army contract worth up to $785M »

Jacobs has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VAC

Marriott Vacations

$95.57

-0.48 (-0.50%)

07:46
03/20/19
03/20
07:46
03/20/19
07:46
Initiation
Marriott Vacations initiated  »

Marriott Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$184.29

0.88 (0.48%)

07:46
03/20/19
03/20
07:46
03/20/19
07:46
Initiation
Home Depot initiated at Evercore ISI »

Home Depot initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 28

    May

ERI

Eldorado Resorts

, CZR

Caesars

$8.53

0.06 (0.71%)

07:45
03/20/19
03/20
07:45
03/20/19
07:45
Recommendations
Eldorado Resorts, Caesars analyst commentary  »

Eldorado shares could be…

ERI

Eldorado Resorts

CZR

Caesars

$8.53

0.06 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$26.58

0.33 (1.26%)

07:45
03/20/19
03/20
07:45
03/20/19
07:45
Initiation
MGM Resorts initiated  »

MGM Resorts assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TME

Tencent Music

$18.65

-0.48 (-2.51%)

07:45
03/20/19
03/20
07:45
03/20/19
07:45
Downgrade
Tencent Music rating change  »

Tencent Music downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVRO

Nevro

$44.76

0.37 (0.83%)

07:45
03/20/19
03/20
07:45
03/20/19
07:45
Hot Stocks
Breaking Hot Stocks news story on Nevro »

Nevro up 21% to $54.26…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

FND

Floor & Decor

$38.77

0.395 (1.03%)

07:44
03/20/19
03/20
07:44
03/20/19
07:44
Initiation
Floor & Decor initiated  »

Floor & Decor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNTY

Century Casinos

$8.75

-0.04 (-0.46%)

07:43
03/20/19
03/20
07:43
03/20/19
07:43
Downgrade
Century Casinos rating change  »

Century Casinos…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 07

    Jun

LVS

Las Vegas Sands

$59.29

-0.045 (-0.08%)

07:43
03/20/19
03/20
07:43
03/20/19
07:43
Initiation
Las Vegas Sands initiated  »

Las Vegas Sands assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.